Spirulina is a natural algae powder known as cyanobacteria that comprises potent level of proteins, antioxidants, and vitamin B and other nutrients. Spirulina exhibits various benefits such as lowering of LDL and triglyceride levels and anticancer properties. It also reduces blood pressure, is effective against anemia, and improves muscle strength. The global spirulina market generated $348 million in 2018, and is projected to reach $779 million by 2026, growing at a CAGR of 10.5% from 2019 to 2026.
The increase in use of spirulina as a dietary food supplement, owing to its high nutritional content is the major factor that drives the spirulina market. Furthermore, increase in adoption of healthy food in developed countries fuel the market growth of spirulina in food & beverages. The rise in prevalence of cancer, cardiovascular diseases, immune diseases, and other diseases boosts the demand of spirulina.
Furthermore, increase in healthcare expenditure and disposable income among the population is anticipated to increase the market growth. However, limited resource of spirulina as it is extracted from the freshwater sources that are available in very few areas hinders the market growth. Emerging economies such as India, China, Mexico, and Brazil are anticipated to provide new opportunities for the market growth during the forecast period.
The global spirulina market is segmented into type, application, drug formulation, and region. By type, the market is bifurcated into Arthrospira Platensis and Arthrospira Platensis. Based on application, it is categorized into nutraceuticals, cosmetics, food & beverages, agriculture, feed, and others. Based on drug formulation, the spirulina market is categorized into powder, tablet & capsule, liquid, and granule & gelling agent. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
ü This report highlights the market dynamics to understand the global spirulina market and capitalize on the prevailing opportunities.
ü Quantitative analysis of the current market and forecasts would assist stakeholders to design business strategies accordingly.
ü Porter's five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
ü Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.
KEY MARKET SEGMENTS
• By Type
o Arthrospira Platensis
o Arthrospira Maxima
• By Application
o Nutraceuticals
o Food & Beverages
o Cosmetics
o Animal Feed
o Others
• By Drug Formulation
o Powder
o Tablet & Capsule
o Liquid
o Granule & Gelling Agent
• By Region
o North America
• U.S.
• Canada
• Mexico
o Europe
• Germany
• France
• Spain
• Italy
• UK
• Rest of Europe
o Asia-Pacific
• Australia
• Japan
• India
• China
• Rest of Asia-Pacific
o LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA
KEY MARKET PLAYERS
• Cyanotech
• DIC Corporation
• Chr. Hansen Holding A/S
• Dongtai City Spirulina Bio-engineering Co., Ltd.
• Algenol Biofuels Inc
• Prolgae
• Sensient Technologies Corporation
• Parry Neutraceuticals
• Algatec
The other players in the value chain include (profiles not included in the report):
• GNC Holdings, Inc.
• Now Health Group Inc.
• Fuqing King Dnarmsa Spirulina Co.
• Fraken Biochem Co., Ltd.
• Far East Bio-Tec Co. Ltd.
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools & Models
Chapter 2: Executive Summary
2.1. Key Findings
2.1.1. Top Investment Pockets
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Spirulina Market
3.3.1. Moderate Bargaining Power of Suppliers
3.3.2. High Bargaining Power of Buyers
3.3.3. High Threat of New Entrants
3.3.4. Moderate Threat of Substitutes
3.3.5. High Intensity of Rivalry
3.4. Pricing Analysis
3.4.1. Pricing Analysis, By Region, 2019 & 2026
3.5. Market Evolution/Industry Roadmap
3.6. Value Chain Analysis
3.7. Impact of Government Regulations On Global Spirulina Market
3.8. Industry Pain Point Analysis
3.9. Patent Analysis
3.9.1. By Region (2017-2019)
3.9.2. By Applicant
3.9.3. By Year
3.10. Market Share Analysis
3.11. Case Studies
3.11.1. Case Study
3.12. Market Dynamics
3.12.1. Drivers
3.12.1.1. Increase In Demand For Natural Ingredient
3.12.1.2. Promotion of The Production of Spirulina By Government
3.12.1.3. R&D of Spirulina As Commercial Products
3.12.2. Restraints
3.12.2.1. Impact On Spirulina Production Due To Climate Change
3.12.3. Opportunities
3.12.3.1. Untapped Markets In The Developing Countries
3.12.3.2. Easy To Cultivate Due To Development In Cultivation Technology
3.13. Market Trends
3.13.1. U.S.
3.13.2. China
3.14. False Perception On The Use of Spirulina
3.15. How The Companies Have Reacted To The Negative Information
3.16. Marketing Strategies For Production Segments
3.17. Trends For Consumption In Distinct European Market
3.18. Use of Spirulina For Animal Feeding
Chapter 4: Spirulina Market, By Type
4.1. Overview
4.1.1. Market Size And Forecast, By Consumption Side
4.1.2. Market Size And Forecast, By Production Side
4.2. Arthrospira Platensis
4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast, By Consumption Side
4.2.3. Market Size And Forecast, By Production Side
4.2.4. Market Analysis, By Country
4.3. Arthrospira Maxima
4.3.1. Key Market Trends And Opportunities
4.3.2. Market Size And Forecast, By Consumption Side
4.3.3. Market Size And Forecast, By Production Side
4.3.4. Market Analysis, By Country
Chapter 5: Spirulina Market, By Application
5.1. Overview
5.1.1. Market Size And Forecast, By Consumption Side
5.1.2. Market Size And Forecast, By Production Side
5.2. Nutraceuticals
5.2.1. Key Market Trends And Opportunities
5.2.2. Market Size And Forecast, By Consumption Side
5.2.3. Market Size And Forecast, By Production Side
5.2.4. Market Analysis, By Country
5.3. Cosmetics
5.3.1. Key Market Trends And Opportunities
5.3.2. Market Size And Forecast, By Consumption Side
5.3.3. Market Size And Forecast, By Production Side
5.3.4. Market Analysis, By Country
5.4. Food And Beverages
5.4.1. Key Market Trends And Opportunities
5.4.2. Market Size And Forecast, By Consumption Side
5.4.3. Market Size And Forecast, By Production Side
5.4.4. Market Analysis, By Country
5.5. Animal Feed
5.5.1. Key Market Trends And Opportunities
5.5.2. Market Size And Forecast, By Consumption Side
5.5.3. Market Size And Forecast, By Production Side
5.5.4. Market Analysis, By Country
5.6. Other Applications
5.6.1. Key Market Trends And Opportunities
5.6.2. Market Size And Forecast, By Consumption Side
5.6.3. Market Size And Forecast, By Production Side
5.6.4. Market Analysis, By Country
Chapter 6: Spirulina Market, By Drug Formulation
6.1. Overview
6.1.1. Market Size And Forecast, By Consumption Side
6.1.2. Market Size And Forecast, By Production Side
6.2. Powder
6.2.1. Key Market Trends And Opportunities
6.2.2. Market Size And Forecast, By Consumption Side
6.2.3. Market Size And Forecast, By Production Side
6.2.4. Market Analysis, By Country
6.3. Tablet & Capsule
6.3.1. Key Market Trends And Opportunities
6.3.2. Market Size And Forecast, By Consumption Side
6.3.3. Market Size And Forecast, By Production Side
6.3.4. Market Analysis, By Country
6.4. Liquid
6.4.1. Key Market Trends And Opportunities
6.4.2. Market Size And Forecast, By Consumption Side
6.4.3. Market Size And Forecast, By Production Side
6.4.4. Market Analysis, By Country
6.5. Granule & Gelling Agent
6.5.1. Key Market Trends And Opportunities
6.5.2. Market Size And Forecast, By Consumption Side
6.5.3. Market Size And Forecast, By Production Side
6.5.4. Market Analysis, By Country
Chapter 7: Spirulina Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.1.2. Market Size And Forecast, By Production Side
7.2. North America
7.2.1. Key Market Trends And Opportunities
7.2.2. North America Market Size And Forecast, By Type
7.2.3. North America Market Size And Forecast, By Application
7.2.4. North America Market Size And Forecast, By Drug Formulation
7.2.5. North America Market Size And Forecast, By Country
7.2.5.1. U.S. Market Size And Forecast, By Type
7.2.5.2. U.S. Market Size And Forecast, By Application
7.2.5.3. U.S. Market Size And Forecast, By Drug Formulation
7.2.5.4. Canada Market Size And Forecast, By Type
7.2.5.5. Canada Market Size And Forecast, By Application
7.2.5.6. Canada Market Size And Forecast, By Drug Formulation
7.2.5.7. Mexico Market Size And Forecast, By Type
7.2.5.8. Mexico Market Size And Forecast, By Application
7.2.5.9. Mexico Market Size And Forecast, By Drug Formulation
7.3. Europe
7.3.1. Key Market Trends And Opportunities
7.3.2. Europe Market Size And Forecast, By Type
7.3.3. Europe Market Size And Forecast, By Application
7.3.4. Europe Market Size And Forecast, By Drug Formulation
7.3.5. Europe Market Size And Forecast, By Country
7.3.5.1. Germany Market Size And Forecast, By Type
7.3.5.2. Germany Market Size And Forecast, By Application
7.3.5.3. Germany Market Size And Forecast, By Drug Formulation
7.3.5.4. France Market Size And Forecast, By Type
7.3.5.5. France Market Size And Forecast, By Application
7.3.5.6. France Market Size And Forecast, By Drug Formulation
7.3.5.7. Uk Market Size And Forecast, By Type
7.3.5.8. Uk Market Size And Forecast, By Application
7.3.5.9. Uk Market Size And Forecast, By Drug Formulation
7.3.5.10. Italy Market Size And Forecast, By Type
7.3.5.11. Italy Market Size And Forecast, By Application
7.3.5.12. Italy Market Size And Forecast, By Drug Formulation
7.3.5.13. Spain Market Size And Forecast, By Type
7.3.5.14. Spain Market Size And Forecast, By Application
7.3.5.15. Spain Market Size And Forecast, By Drug Formulation
7.3.5.16. Rest of Europe Market Size And Forecast, By Type
7.3.5.17. Rest of Europe Market Size And Forecast, By Application
7.3.5.18. Rest of Europe Market Size And Forecast, By Drug Formulation
7.4. Asia-Pacific
7.4.1. Key Market Trends And Opportunities
7.4.2. Asia-Pacific Market Size And Forecast, By Type
7.4.3. Asia-Pacific Market Size And Forecast, By Application
7.4.4. Asia-Pacific Market Size And Forecast, By Drug Formulation
7.4.5. Asia-Pacific Market Size And Forecast, By Country
7.4.5.1. Japan Market Size And Forecast, By Type
7.4.5.2. Japan Market Size And Forecast, By Application
7.4.5.3. Japan Market Size And Forecast, By Drug Formulation
7.4.5.4. China Market Size And Forecast, By Type
7.4.5.5. China Market Size And Forecast, By Application
7.4.5.6. China Market Size And Forecast, By Drug Formulation
7.4.5.7. India Market Size And Forecast, By Type
7.4.5.8. India Market Size And Forecast, By Application
7.4.5.9. India Market Size And Forecast, By Drug Formulation
7.4.5.10. Australia Market Size And Forecast, By Type
7.4.5.11. Australia Market Size And Forecast, By Application
7.4.5.12. Australia Market Size And Forecast, By Drug Formulation
7.4.5.13. Rest of Asia-Pacific Market Size And Forecast, By Type
7.4.5.14. Rest of Asia-Pacific Market Size And Forecast, By Application
7.4.5.15. Rest of Asia-Pacific Market Size And Forecast, By Drug Formulation
7.5. Lamea
7.5.1. Key Market Trends And Opportunities
7.5.2. Lamea Market Size And Forecast, By Type
7.5.3. Lamea Market Size And Forecast, By Application
7.5.4. Lamea Market Size And Forecast, By Drug Formulation
7.5.5. Lamea Market Size And Forecast, By Country
7.5.5.1. Brazil Market Size And Forecast, By Type
7.5.5.2. Brazil Market Size And Forecast, By Application
7.5.5.3. Brazil Market Size And Forecast, By Drug Formulation
7.5.5.4. South Africa Market Size And Forecast, By Type
7.5.5.5. South Africa Market Size And Forecast, By Application
7.5.5.6. South Africa Market Size And Forecast, By Drug Formulation
7.5.5.7. Rest of Lamea Market Size And Forecast, By Type
7.5.5.8. Rest of Lamea Market Size And Forecast, By Application
7.5.5.9. Rest of Lamea Market Size And Forecast, By Drug Formulation
Chapter 8: Company Profiles
8.1. Algenol Biofuels Inc.
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.2. Cabassi & Giuriati Spa
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Key Strategic Moves And Developments
8.3. Chr. Hansen Holding A/S
8.3.1. Company Overview
8.3.2. Chr. Hansen: Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Business Performance
8.4. Cyane
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Product Portfolio
8.5. Cyanotech Corporation
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance
8.6. Ddw Inc.
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.7. Dic Corporation
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Business Performance
8.8. Döhler Gmbh
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.9. Dongtai City Spirulina Bio-Engineering Co, Ltd.
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.10. Echlorial
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.11. E.I.D. Parry Limited
8.11.1. Company Overview
8.11.2. Company Snapshot
8.11.3. Operating Business Segments
8.11.4. Product Portfolio
8.11.5. Business Performance
8.12. Givaudan International Sa
8.12.1. Company Overview
8.12.2. Company Snapshot
8.12.3. Operating Business Segments
8.12.4. Product Portfolio
8.12.5. Business Performance
8.13. Prolgae Spirulina Supplies Pvt. Ltd.
8.13.1. Company Overview
8.13.2. Company Snapshot
8.13.3. Operating Business Segments
8.14. Pond Technologies Inc.
8.14.1. Company Overview
8.14.2. Company Snapshot
8.14.3. Operating Business Segments
8.14.4. Product Portfolio
8.15. Sensient Technologies Corporation
8.15.1. Company Overview
8.15.2. Company Snapshot
8.15.3. Operating Business Segments
8.15.4. Product Portfolio
8.15.5. Business Performance
